Mereo BioPharma 2025 AGM: all resolutions pass; board elects annual say-on-pay

Mereo BioPharma Group plc

Resolutions 1-5 and 7-9 passed with over 85% of votes cast.
Resolution 6 (advisory vote on frequency of exec comp) received 48% for 1-year, 46% for 3-year; board chooses annual frequency until 2031.
Re-elected directors Deepika Pakianathan, Pierre Jacquet, Michael Wyzga each won >85% support.
PricewaterhouseCoopers re-appointed as auditor with 99.58% of votes cast.
Total 624,188,662 ordinary shares represented at the meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.